NCT02972476View on ClinicalTrials.gov

Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 22, 2019

Study Completion Date

July 22, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Budesonide & formoterol fumarate and Aclidinium bromide

DRUG

Fluticasone 500 & salmeterol and Aclidinium bromide

DRUG

Fluticasone 250 & salmeterol and Aclidinium bromide

DRUG

Aclidinium bromide & formoterol fumarate

Trial Locations (6)

DD1 9SY

NHS Tayside, Dundee

FY3 8NR

Blackpool Teaching Hospital NHS Foundation Trust, Blackpool

EH16 4TJ

NHS Lothian, Edinburgh

Unknown

NHS Greater Glasgow and Clyde, Glasgow

KY2 5AH

NHS Fife, Kirkcaldy

ML2 0DP

NHS Lanarkshire, Wishaw

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

NHS Tayside

OTHER_GOV

lead

University of Dundee

OTHER

NCT02972476 - Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial | Biotech Hunter | Biotech Hunter